What is Gammagard, and what is it used for?
Gammagard (sometimes written as Gammagard Liquid or Gammagard S/D depending on the product) is a brand of intravenous immune globulin (IVIG). IVIG is made from pooled human plasma and is used to provide passive immunity. [1][2]
Common medical uses include treating certain primary immunodeficiency disorders and preventing infections in people who don’t make enough of their own antibodies. Gammagard is also used in some immune-mediated conditions, depending on the approved indication in a given country. [1][2]
What’s the difference between Gammagard and related IVIG products?
Gammagard is one IVIG product among many. Differences between IVIG brands often include formulation and how they are manufactured/treated (for example, some are labeled “S/D,” which refers to virus inactivation steps used during production). Those manufacturing differences can affect packaging, dosing schedules, and sometimes patient tolerability, but all are IVIG therapies delivering antibodies. [1][2]
How is Gammagard given, and how long does treatment take?
Gammagard is given by intravenous infusion. The dosing depends on the condition being treated, the person’s weight, and the specific product label used. Treatment courses can be ongoing or intermittent; many immunodeficiency regimens are given periodically (for example, on a multi-week schedule) to maintain protective antibody levels. [1]
What side effects do patients ask about?
IVIG products can cause infusion-related reactions. Patients commonly ask about symptoms like headache, fever, chills, fatigue, or nausea during or after an infusion. Because IVIG is a blood-derived product administered at relatively high doses, clinicians also watch for rare but serious complications such as kidney problems and blood clotting risks, especially in people with risk factors. [2]
How does Gammagard work?
Gammagard provides concentrated antibodies from donated plasma. In immunodeficiency disorders, it helps replace missing antibodies to reduce the risk of infections. In some immune-mediated diseases, IVIG modulates immune activity through multiple mechanisms, which helps lower abnormal immune responses. [2]
Who typically should be cautious with IVIG like Gammagard?
Risk depends on the patient and the specific product, but clinicians generally pay extra attention to people with:
- prior kidney disease or risk factors for acute kidney injury,
- a history of blood clots or risk factors for hypercoagulability,
- conditions where high infusion volumes or certain components could pose risks. [2]
Where can you find the official labeling for dosing and indications?
The most reliable details for exact indications, dosing, and safety warnings are in the product’s prescribing information (package insert) for your specific Gammagard version (e.g., Liquid, S/D) and country. [1][2]
---
Sources
- https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
- https://dailymed.nlm.nih.gov/